TP53 and ovarian adenocarcinoma: A study examining gene expression by cDNA microarray in a pair of p53+/+ ovarian adenocarcinoma cell lines (KFr and its acquired CDDP resistant counterpart KFrP200) showed a number of gene changes (Sakamoto et al, 2001).